Stay at the forefront of precision medicine with the 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe—the industry-leading end-to-end forum for advancing biomarker and companion diagnostic development in Alzheimer’s, MS, cardiovascular disease, rare genetic disorders, and cancer.
Download the eBook
The official event guide is your essential resource for tackling challenges in biomarker validation, regulatory filing, scalable diagnostic workflows, and IVDR compliance, all while navigating reimbursement pathways for successful commercialization.
With 170+ key European stakeholders, this summit is your premium platform for networking, collaboration, and driving precision drugs from discovery to patient impact.
Download your copy now and accelerate biomarker-driven innovation in 2025.
Download the eBook
About Hanson Wade Group - 15th World Clinical Biomarkers & CDx Europe
Welcome to the 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe.
With drug-diagnostic co-development partnerships fueling advances in diagnostic testing for Alzheimer’s, Multiple Sclerosis, cardiovascular disease, rare genetic disorders, and cancer, 2025 is poised as a critical year for Europe’s precision medicine community. However, developing, clinically validating, regulatory filing and commercialising biomarkers and in vitro diagnostics remains no easy feat, as knowledge gaps persist in validating surrogate endpoints, co-developing scalable diagnostic testing workflows and infrastructure, navigating reimbursement pathways, and harmonising drug-diagnostic IVDR-adherence for approval in unmet patient need.
The 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe returns as the industry-leading end-to-end forum for Europe’s precision medicine community. Serving as your premium connection-making platform, this summit will unite over 170 key European stakeholders to accelerate precision drugs from discovery through to commercialisation for patients in need.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.